Arkema SA (OTCMKTS:ARKAY – Get Free Report) shares gapped up prior to trading on Wednesday . The stock had previously closed at $60.56, but opened at $67.65. Arkema shares last traded at $68.09, with a volume of 458 shares changing hands.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on ARKAY shares. Deutsche Bank Aktiengesellschaft lowered shares of Arkema from a “buy” rating to a “hold” rating in a research note on Monday, November 24th. Barclays cut shares of Arkema from a “hold” rating to a “strong sell” rating in a report on Tuesday, November 11th. Finally, Zacks Research lowered shares of Arkema from a “hold” rating to a “strong sell” rating in a report on Tuesday, January 6th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Reduce”.
Get Our Latest Stock Report on Arkema
Arkema Stock Performance
Arkema (OTCMKTS:ARKAY – Get Free Report) last posted its earnings results on Friday, November 7th. The basic materials company reported $1.19 EPS for the quarter, topping the consensus estimate of $0.98 by $0.21. Arkema had a net margin of 1.55% and a return on equity of 5.15%. The company had revenue of $2.52 billion during the quarter, compared to the consensus estimate of $2.50 billion. On average, analysts forecast that Arkema SA will post 8.36 earnings per share for the current year.
Arkema Company Profile
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Recommended Stories
- Five stocks we like better than Arkema
- NEW LAW: Congress Approves Setup For Digital Dollar?
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- What a Former CIA Agent Knows About the Coming Collapse
- Trade this between 9:30 and 10:45 am EST
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
